Author | Jesper Andersen, PhD | OncLive

Author | Jesper Andersen, PhD

Articles

Challenges Facing the Future of Cholangiocarcinoma

May 19, 2017

Video

Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the challenges facing the future treatment of patients with cholangiocarcinoma.

Relationship Between OCT1 Expression and Poor Response to Sorafenib in HCC

April 21, 2017

Video

Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the relationship between reduced organic cation transporter-1 (OCT1) and poor response to sorafenib (Nexavar) in hepatocellular carcinoma (HCC) and cholangiocarcinoma.

x